Reduction in circulating ghrelin concentration after maturation does not affect food intake

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, et al. (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. <i>Nature </i>402: 656-660.

2. Ariyasu H, Takaya K, Tagami T, Ogawa Y, Hosoda K, et al. (2001) Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. <i>J Clin Endocrinol Metab</i> 86: 4753-4758.

3. Hosoda H, Kojima M, Matsuo H, Kangawa K (2000) Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. <i>Biochem Biophys Res Commun</i> 279: 909-913.

4. Smith RG, Van der Ploeg LH, Howard AD, Feighner SD, Cheng K, et al. (1997) Peptidomimetic regulation of growth hormone secretion. <i>Endocr Rev </i>18: 621-645.

5. Guan XM, Yu H, Palyha OC, McKee KK, Feighner SD, et al. (1997) Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. <i>Brain Res Mol Brain Res</i> 48: 23-29.

6. Mitchell V, Bouret S, Beauvillain JC, Schilling A, Perret M, et al. (2001) Comparative distribution of mRNA encoding the growth hormone secretagogue-receptor (GHS-R) in Microcebus murinus (Primate, lemurian) and rat forebrain and pituitary.<i> J Comp Neurol </i>429: 469-489.

7. Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, et al. (2000) Ghrelin strongly stimulates growth hormone release in humans. <i>J Clin Endocrinol Metab </i>85: 4908-4911.

8. Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, et al. (2001) Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. <i>Diabetes</i> 50: 227-232.

9. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, et al. (2001) A role for ghrelin in the central regulation of feeding. <i>Nature </i>409: 194-198.

10. Tsch&ouml;p M, Smiley DL, Heiman ML (2000) Ghrelin induces adiposity in rodents. <i>Nature</i> 407: 908-913.

11. Wren AM, Small CJ, Abbott CR, Dhillo WS, Seal LJ, et al. (2001) Ghrelin causes hyperphagia and obesity in rats. <i>Diabetes</i> 50: 2540-2547.

12. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, et al. (2002) Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. <i>N Engl J Med</i> 346: 1623-1630.

13. Sun Y, Ahmed S, Smith RG (2003) Deletion of ghrelin impairs neither growth nor appetite. <i>Mol Cell Biol</i> 23: 7973-7981.

14. Wortley KE, Anderson KD, Garcia K, Murray JD, Malinova L, et al. (2004) Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. <i>Proc Natl Acad Sci U S A </i>101: 8227-8232.

15. Sun Y, Wang P, Zheng H, Smith RG (2004) Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. <i>Proc Natl Acad Sci U S A </i>101: 4679-4684.

16. Sato T, Kurokawa M, Nakashima Y, Ida T, Takahashi T, et al. (2008) Ghrelin deficiency does not influence feeding performance. <i>Regul Pept </i>145: 7-11.

17. Ariyasu H, Iwakura H, Yamada G, Kanamoto N, Bando M, et al. (2010) A postweaning reduction in circulating ghrelin temporarily alters growth hormone (GH) responsiveness to GH-releasing hormone in male mice but does not affect somatic growth. <i>Endocrinology</i> 151: 1743-1750.

18. Iwakura H, Akamizu T, Ariyasu H, Irako T, Hosoda K, et al. (2007) Effects of ghrelin administration on decreased growth hormone status in obese animals. <i>Am J Physiol Endocrinol Metab</i> 293: E819-825.

19. Ogilvie KM, Saladin R, Nagy TR, Urcan MS, Heyman RA, et al. (2004) Activation of the retinoid X receptor suppresses appetite in the rat. <i>Endocrinology</i> 145: 565-573.

20. Kowalski TJ, Farley C, Cohen-Williams ME, Varty G, Spar BD (2004) Melanin-concentrating hormone-1 receptor antagonism decreases feeding by reducing meal size. <i>Eur J Pharmacol </i>497: 41-47.

21. Gong L, Yao F, Hockman K, Heng HH, Morton GJ, et al. (2008) Signal transducer and activator of transcription-3 is required in hypothalamic agouti-related protein/neuropeptide Y neurons for normal energy homeostasis. <i>Endocrinology</i> 149: 3346-3354.

22. Gammie SC, Hasen NS, Awad TA, Auger AP, Jessen HM, et al. (2005) Gene array profiling of large hypothalamic CNS regions in lactating and randomly cycling virgin mice. <i>Brain Res Mol Brain Res</i> 139: 201-211.

23. Minokoshi Y, Alquier T, Furukawa N, Kim YB, Lee A, et al. (2004) AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. <i>Nature</i> 428: 569-574.

24. Bohnet SG, Traynor TR, Majde JA, Kacsoh B, Krueger JM (2004) Mice deficient in the interferon type I receptor have reduced REM sleep and altered hypothalamic hypocretin, prolactin and 2&rsquo;,5&rsquo;-oligoadenylate synthetase expression. <i>Brain Res </i>1027: 117-125.

25. Negishi T, Kawasaki K, Suzaki S, Maeda H, Ishii Y, et al. (2004) Behavioral alterations in response to fear-provoking stimuli and tranylcypromine induced by perinatal exposure to bisphenol A and nonylphenol in male rats. <i>Environ Health Perspect</i> 112: 1159-1164.

26. Ishihara K, Oyaizu S, Mizunoya W, Fukuchi Y, Yasumoto K, et al. (2002) Use of ¹³C-labeled glucose for measuring exogenous glucose oxidation in mice. <i>Biosci Biotechnol Biochem</i> 66: 426-429.

27. Ishihara K, Oyaizu S, Onuki K, Lim K, Fushiki T (2000) Chronic (-)-hydroxycitrate administration spares carbohydrate utilization and promotes lipid oxidation during exercise in mice. <i>J Nutr </i>130: 2990-2995.

28. Frayn KN (1983) Calculation of substrate oxidation rates in vivo from gaseous exchange. <i>J Appl Physiol Respir Environ Exerc Physiol </i>55: 628-634.

29. Small CJ, Bloom SR (2004) Gut hormones and the control of appetite.<i> Trends Endocrinol Metab.</i> 15: 259-263.

30. Wren AM (2008) Gut and hormones and obesity. <i>Front Horm Res</i> 36: 165-181.

31. Cummings DE (2006) Ghrelin and the short- and long-term regulation of appetite and body weight.<i> Physiol Behav</i> 89: 71-84.

32. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, et al. (2001) Ghrelin enhances appetite and increases food intake in humans.<i> J Clin Endocrinol Metab</i> 86: 5992.

33. Luquet S, Perez FA, Hnasko TS, Palmiter RD (2005) NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. <i>Science</i> 310: 683-685.

34. Wortley KE, del Rincon JP, Murray JD, Garcia K, Iida K, et al. (2005) Absence of ghrelin protects against early-onset obesity. <i>J Clin Invest</i> 115: 3573-3578.

35. Zigman JM, Nakano Y, Coppari R, Balthasar N, Marcus JN, et al. (2005) Mice lacking ghrelin receptors resist the development of diet-induced obesity. <i>J Clin Invest </i>115: 3564-3572.

36. Davies JS, Kotokorpi P, Eccles SR, Barnes SK, Tokarczuk PF, et al. (2009) Ghrelin induces abdominal obesity via GHS-R-dependent lipid retention. <i>Mol Endocrinol</i> 23: 914-924.

37. Baragli A, Gh&egrave; C, Arnoletti E, Granata R, Ghigo E, et al. (2011) Acylated and unacylated ghrelin attenuate isoproterenol-induced lipolysis in isolated rat visceral adipocytes through activation of phosphoinositide 3-kinase &gamma; and phosphodiesterase 3B. <i>Biochim Biophys Acta </i>1811: 386-396.

38. Muccioli G, Pons N, Gh&egrave; C, Catapano F, Granata R, et al. (2004) Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor. <i>Eur J Pharmacol </i>498: 27-35.

39. Goldstein DJ (1992) Beneficial health effects of modest weight loss. <i>Int J Obes Relat Metab Disord </i>16: 397-415.

40. Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, et al. (2004) Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. <i>Health Technol Assess </i>8: iii-iv, 1-182.

41. Gregg EW, Gerzoff RB, Thompson TJ, Williamson DF (2003) Intentional weight loss and death in overweight and obese U.S. adults 35 years of age and older. <i>Ann Intern Med</i> 138: 383-389.

42. McFarlane MR, Brown MS, Goldstein JL, Zhao TJ (2014) Induced ablation of ghrelin cells in adult mice does not decrease food intake, body weight, or response to high-fat diet. <i>Cell Metab</i> 20: 54-60.